Prosecution Insights
Last updated: August 18, 2026

Examiner: PATEL, SAGAR S

Tech Center 1600 • Art Units: 1626 1654

This examiner grants 76% of resolved cases

Performance Statistics

76.0%
Allow Rate
+16.0% vs TC avg
493
Total Applications
+34.4%
Interview Lift
925
Avg Prosecution Days
Based on 466 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
19.8%
§102 Novelty
38.0%
§103 Obviousness
24.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17350374 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS Non-Final OA SYNGENTA PARTICIPATIONS AG
17093833 OXAZOLIDINONE COMPOUNDS AND METHODS OF USE THEREOF AS ANTIBACTERIAL AGENTS Final Rejection Merck Sharp & Dohme LLC
17314196 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AND METHODS OF USE Final Rejection The Trustees of Princeton University
18840382 SYNTHESIS METHOD FOR ALKYLENE CARBONATE Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18272980 ANTIBACTERIAL PEPTIDES AND COMPOUNDS TARGETING TOXIN-ANTITOXIN SYSTEM OF KLEBSIELLA PNEUMONIAE, AND THEIR USE Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18670859 NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER Non-Final OA Novartis AG
18376187 Methods of Treating Diabetic Cardiomyopathy by Inhibiting GLUT1 Final Rejection University of Cincinnati

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month